Literature DB >> 20064935

Nuclear aggregation of polyglutamine-expanded ataxin-3: fragments escape the cytoplasmic quality control.

Peter Breuer1, Annette Haacke, Bernd O Evert, Ullrich Wüllner.   

Abstract

Expansion of a polymorphic polyglutamine segment is the common denominator of neurodegenerative polyglutamine diseases. The expanded proteins typically accumulate in large intranuclear inclusions and induce neurodegeneration. However, the mechanisms that determine the subcellular site and rate of inclusion formation are largely unknown. We found that the conserved putative nuclear localization sequence Arg-Lys-Arg-Arg, which is retained in a highly aggregation-prone fragment of ataxin-3, did not affect the site and degree of inclusion formation in a cell culture model of spinocerebellar ataxia type 3. Addition of synthetic nuclear export or import signals led to the expected localization of ataxin-3 and determined the subcellular site of aggregate formation. Triggering a cellular stress response by heat shock transcription factor DeltaHSF1 coexpression abrogated aggregation in the cytoplasm but not in the nucleus. These findings indicate that native aggregation-prone fragments derived from expanded ataxin-3 may eventually escape the cytoplasmic quality control, resulting in aggregation in the nuclear compartment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20064935      PMCID: PMC2825449          DOI: 10.1074/jbc.M109.036335

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

Review 1.  The proteasome and its role in nuclear protein maintenance.

Authors:  Nicolle Bader; Tobias Jung; Tilman Grune
Journal:  Exp Gerontol       Date:  2007-04-10       Impact factor: 4.032

2.  Calpain inhibition is sufficient to suppress aggregation of polyglutamine-expanded ataxin-3.

Authors:  Annette Haacke; F Ulrich Hartl; Peter Breuer
Journal:  J Biol Chem       Date:  2007-05-08       Impact factor: 5.157

Review 3.  Polyglutamine gene function and dysfunction in the ageing brain.

Authors:  Sarah Hands; Christopher Sinadinos; Andreas Wyttenbach
Journal:  Biochim Biophys Acta       Date:  2008-06-05

4.  The degree of macromolecular crowding in the cytoplasm and nucleoplasm of mammalian cells is conserved.

Authors:  Gernot Guigas; Claudia Kalla; Matthias Weiss
Journal:  FEBS Lett       Date:  2007-10-02       Impact factor: 4.124

5.  Proteolytic cleavage of polyglutamine-expanded ataxin-3 is critical for aggregation and sequestration of non-expanded ataxin-3.

Authors:  Annette Haacke; Sarah A Broadley; Raina Boteva; Nikolay Tzvetkov; F Ulrich Hartl; Peter Breuer
Journal:  Hum Mol Genet       Date:  2006-01-11       Impact factor: 6.150

6.  Comparison of intra-organellar chaperone capacity for dealing with stress-induced protein unfolding.

Authors:  Jurre Hageman; Michel J Vos; Maria A W H van Waarde; Harm H Kampinga
Journal:  J Biol Chem       Date:  2007-09-17       Impact factor: 5.157

7.  Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidence.

Authors:  Ulrike Bichelmeier; Thorsten Schmidt; Jeannette Hübener; Jana Boy; Lukas Rüttiger; Karina Häbig; Sven Poths; Michael Bonin; Marlies Knipper; Werner J Schmidt; Johannes Wilbertz; Hartwig Wolburg; Franco Laccone; Olaf Riess
Journal:  J Neurosci       Date:  2007-07-11       Impact factor: 6.167

8.  Progressive disruption of cellular protein folding in models of polyglutamine diseases.

Authors:  Tali Gidalevitz; Anat Ben-Zvi; Kim H Ho; Heather R Brignull; Richard I Morimoto
Journal:  Science       Date:  2006-02-09       Impact factor: 63.714

9.  Nuclear polyglutamine-containing protein aggregates as active proteolytic centers.

Authors:  Min Chen; Lena Singer; Andrea Scharf; Anna von Mikecz
Journal:  J Cell Biol       Date:  2008-02-18       Impact factor: 10.539

10.  Autophagy inhibition compromises degradation of ubiquitin-proteasome pathway substrates.

Authors:  Viktor I Korolchuk; Alicia Mansilla; Fiona M Menzies; David C Rubinsztein
Journal:  Mol Cell       Date:  2009-02-27       Impact factor: 17.970

View more
  14 in total

Review 1.  Toward understanding Machado-Joseph disease.

Authors:  Maria do Carmo Costa; Henry L Paulson
Journal:  Prog Neurobiol       Date:  2011-11-23       Impact factor: 11.685

2.  Unravelling Endogenous MicroRNA System Dysfunction as a New Pathophysiological Mechanism in Machado-Joseph Disease.

Authors:  Vitor Carmona; Janete Cunha-Santos; Isabel Onofre; Ana Teresa Simões; Udaya Vijayakumar; Beverly L Davidson; Luís Pereira de Almeida
Journal:  Mol Ther       Date:  2017-02-22       Impact factor: 11.454

3.  Large-scale screen for modifiers of ataxin-3-derived polyglutamine-induced toxicity in Drosophila.

Authors:  Hannes VoSSfeldt; Malte Butzlaff; Katja PrüSSing; Róisín-Ana Ní Chárthaigh; Peter Karsten; Anne Lankes; Sabine Hamm; Mikael Simons; Boris Adryan; Jörg B Schulz; Aaron Voigt
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

4.  Altered expression of carbonic anhydrase-related protein XI in neuronal cells expressing mutant ataxin-3.

Authors:  Mingli Hsieh; Wei-Hsiu Chang; Chi-Fu Hsu; Isao Nishimori; Cheng-Liang Kuo; Tomoko Minakuchi
Journal:  Cerebellum       Date:  2013-06       Impact factor: 3.847

Review 5.  Mutant Ataxin-3-Containing Aggregates (MATAGGs) in Spinocerebellar Ataxia Type 3: Dynamics of the Disorder.

Authors:  Kritika Raj; Ravi Shankar Akundi
Journal:  Mol Neurobiol       Date:  2021-02-24       Impact factor: 5.590

Review 6.  Ataxin-3 protein and RNA toxicity in spinocerebellar ataxia type 3: current insights and emerging therapeutic strategies.

Authors:  Melvin M Evers; Lodewijk J A Toonen; Willeke M C van Roon-Mom
Journal:  Mol Neurobiol       Date:  2013-11-29       Impact factor: 5.590

7.  microRNA dysregulation in polyglutamine toxicity of TATA-box binding protein is mediated through STAT1 in mouse neuronal cells.

Authors:  Reema Roshan; Ashwani Choudhary; Aksheev Bhambri; Bhawani Bakshi; Tanay Ghosh; Beena Pillai
Journal:  J Neuroinflammation       Date:  2017-08-03       Impact factor: 8.322

8.  Rescue of ATXN3 neuronal toxicity in Caenorhabditiselegans by chemical modification of endoplasmic reticulum stress.

Authors:  Yasmin Fardghassemi; Arnaud Tauffenberger; Sarah Gosselin; J Alex Parker
Journal:  Dis Model Mech       Date:  2017-12-19       Impact factor: 5.758

9.  Aggregation of polyglutamine-expanded ataxin-3 sequesters its specific interacting partners into inclusions: implication in a loss-of-function pathology.

Authors:  Hui Yang; Jing-Jing Li; Shuai Liu; Jian Zhao; Ya-Jun Jiang; Ai-Xin Song; Hong-Yu Hu
Journal:  Sci Rep       Date:  2014-09-18       Impact factor: 4.379

10.  SUMO-1 modification on K166 of polyQ-expanded ataxin-3 strengthens its stability and increases its cytotoxicity.

Authors:  Ya-Fang Zhou; Shu-Sheng Liao; Ying-Ying Luo; Jian-Guang Tang; Jun-Ling Wang; Li-Fang Lei; Jing-Wei Chi; Juan Du; Hong Jiang; Kun Xia; Bei-Sha Tang; Lu Shen
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.